State Street Corp Novavax Inc Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Novavax Inc stock. As of the latest transaction made, State Street Corp holds 6,066,179 shares of NVAX stock, worth $75.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,066,179
Previous 16,906,570
64.12%
Holding current value
$75.1 Million
Previous $80.8 Million
4.97%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding NVAX
# of Institutions
284Shares Held
83.2MCall Options Held
5.43MPut Options Held
9M-
Vanguard Group Inc Valley Forge, PA14.1MShares$174 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$147 Million0.0% of portfolio
-
Shah Capital Management9.66MShares$120 Million41.87% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$78.3 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA3.2MShares$39.6 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $968M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...